<DOC>
	<DOCNO>NCT02877407</DOCNO>
	<brief_summary>- objective : aim compare laparoscopic/robot-assisted hysteropexy vaginal hysterectomy uterine prolapse - prospective randomized clinical trial - patient 1 . 60yrs woman 2 . POP-Q stage II symptom POP-Q III , IV regardless symptom - number patient : 146 - randomize : laparoscopic/robot-assisted hysteropexy vs. hysterectomy - follow : postoperative 1 year - primary endpoint : recurrence rate 1. recurrence uterovaginal prolapse POP-Q stage II-IV 2. recurrence associate symptom - secondary endpoint 1. postoperative 1 year QOL , degree satisfaction evaluation 2. operative time , estimate blood loss 3. hospitalization period , postoperative pain , return normal activity</brief_summary>
	<brief_title>Laparoscopic/Robotic-assisted Hysteropexy Versus Vaginal Hysterectomy Treatment Uterovaginal Prolapse</brief_title>
	<detailed_description />
	<mesh_term>Prolapse</mesh_term>
	<criteria>POPQ stage II symptom POPQ III , IV regardless symptom abnormal uterine bleed significantly enlarge fibroid uterus postmenopausal uterine bleed endometrial pathology tamexifen concomitant medical problem preclude general anesthesia surgery damage agreement ability</criteria>
	<gender>Female</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>